CENTRAL CAROLINA HOSPITAL
1. Target Overview & Investment Thesis
CENTRAL CAROLINA HOSPITAL is a 127-bed rural/critical access in LEE, NC with $68.6M in net patient revenue and a -9.0% operating margin. The hospital serves a payer mix of 42.3% Medicare, 17.4% Medicaid, and 40.2% commercial.
Thesis: Undervalued. Our ML models identify $5.0M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -9.0% to -1.6% (+736bps).
| Net Revenue HCRIS | $68.6M |
| Current EBITDA COMPUTED | $-6.2M |
| Operating Margin COMPUTED | -9.0% |
| Occupancy HCRIS | 22.7% |
| Revenue / Bed COMPUTED | $540K |
| Net-to-Gross HCRIS | 16.2% |
| Distress Probability ML | 57.9% |
2. Market Context & Competitive Position
NC has 129 Medicare-certified hospitals with a median operating margin of -2.0%. The target's margin of -9.0% places it below the state median. Among 58 size-comparable peers (64-254 beds), the median margin is -1.3%. The target's below-peer margin suggests operational improvement opportunity.
3. RCM Performance Analysis — Comparable Hospitals
Comps selected by bed count (64-254), prioritizing same-state peers. 58 hospitals in the comp set.
| Hospital | State | Beds | Revenue | Margin |
|---|---|---|---|---|
| CENTRAL CAROLINA HOSPITAL (Target) | NC | 127 | $68.6M | -9.0% |
| DUKE RALEIGH HOSPITAL | NC | 186 | $683.0M | 3.7% |
| CATAWBA VALLEY MEDICAL CENTER | NC | 200 | $451.9M | 5.9% |
| MARGARET R. PARDEE MEMORIAL HO | NC | 160 | $341.3M | -5.7% |
| JOHNSTON HEALTH | NC | 179 | $331.7M | 9.6% |
| WAKE MED CARY HOSPITAL | NC | 189 | $318.1M | -3.6% |
| ATRIUM HEALTH UNION | NC | 183 | $302.3M | 7.0% |
| S.E. REGL MEDICAL CENTER | NC | 179 | $298.1M | -25.3% |
| WAYNE MEMORIAL HOSPITAL | NC | 245 | $295.1M | 8.9% |
4. Predicted Improvement Opportunities
Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $5.0M (736bps margin improvement).
| Lever | Current | Target | EBITDA Impact | Margin | Ramp |
|---|---|---|---|---|---|
| Net Collection Rate | 93.5% | 97.0% | $1.4M | +210bp | 18mo |
| Cost to Collect | 4.5% | 2.5% | $1.4M | +200bp | 12mo |
| Denial Rate Reduction | 12.0% | 6.5% | $1.4M | +198bp | 12mo |
| A/R Days Reduction | 5200.0% | 3800.0% | $834K | +122bp | 9mo |
| Clean Claim Rate | 88.0% | 96.0% | $44K | +6bp | 6mo |
5. EBITDA Bridge
| Current EBITDA | $-6.2M |
| + RCM Uplift | +$5.0M |
| Pro Forma EBITDA | $-1.1M |
| Current Margin | -9.0% |
| Pro Forma Margin | -1.6% |
| WC Released (1x) | $2.6M |
6. Returns Analysis — Scenario Matrix
5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.
| Scenario | Entry | Exit | Equity In | Equity Out | MOIC | IRR |
|---|---|---|---|---|---|---|
| Base Case | 10.0x | 10.0x | $-9.5M | $9.9M | 0.00x | -100.0% |
| Base (11x exit) | 10.0x | 11.0x | $-9.5M | $7.8M | 0.00x | -100.0% |
| Bull Case | 9.0x | 11.0x | $-8.5M | $21.4M | 0.00x | -100.0% |
| Bull (12x exit) | 9.0x | 12.0x | $-8.5M | $20.8M | 0.00x | -100.0% |
| Bear Case | 11.0x | 10.0x | $-10.4M | $-12.3M | 0.00x | -100.0% |
| Bear (11x exit) | 11.0x | 11.0x | $-10.4M | $-16.9M | 0.00x | -100.0% |
7. Key Risks & Mitigants
| Severity | Risk Factor | Mitigant |
|---|---|---|
| High | Negative operating margin | RCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion |
| Medium | Low occupancy | At 22.7%, fixed costs are spread over fewer patient days. Mitigant: volume growth is an additional upside lever not modeled in base case |
| High | Elevated distress probability | Model estimates 57.9% probability of financial distress. Mitigant: distressed entry pricing (7-9x) compensates for risk |
| Low | Low net-to-gross ratio | Large contractual allowances suggest pricing discipline issues. Mitigant: payer renegotiation is an additional upside lever |
8. Data Sources & Methodology Appendix
Data Sources
- CMS HCRIS Cost Reports (Medicare-certified hospitals)
- CMS Medicare Utilization (DRG-level volumes)
- CMS Chronic Conditions (county-level disease prevalence)
- HCRIS multi-year trend data (financial time series)
Comparable Selection
- 58 hospitals with 64-254 beds
- Same-state prioritization (n=59)
- Comp margins: P25=-8.0% / P50=-1.3% / P75=7.0%
Bridge Methodology
- Targets: P75 of comparable peers (60% gap closure)
- Denial: avoidable share = 35% of delta × NPR
- AR: bad debt coefficient = $0.65 per day per $1K NPR
- NCR: 60% coefficient on collection rate improvement
- CDI: 0.75% of Medicare revenue per 0.01 CMI point
Returns Assumptions
- Leverage: 5.5x entry (84.6% debt / 15.4% equity)
- Organic growth: 3% annual EBITDA growth
- Debt paydown: 10% of principal per year
- Hold period: 5 years
Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.